DTC Fair Balance Review demo
Lays every TV, streaming and social cut out as a timeline of frames, voice-over, supers and music, and times fair balance: benefit time against risk time, and what the picture does under every risk statement. 1:14
What the demo shows
An ad compliance solution for promotional reviewers that checks how DTC ads present risk.
Frames and transcribes each cut, lays it out as a strip of frames with shot-change, voice-over, super and music tracks, and marks where risk information appears and how long it stays on screen. Times benefit against risk and counts what competes with each risk statement, against the issues FDA cited in 2025, and quotes the letter beside each finding.
Transcript
- DTC Fair Balance Review checks how drug ads present risk for promotional reviewers.
- FDA's 2025 letters cited ads whose risks were drowned out by busy pictures.
- Veltremab's 60 second spot, frames, voice-over, supers and music.
- Risk information is marked where it appears and timed on screen.
- We scan it. Benefit gets 31 seconds, the risk's 21.
- At 042, the risk super lands over fast cuts, 8 in under 10 seconds.
- It's flagged as distracting beside the FDA letter on the same issue.
- PREA asks for every revision.
- The agency gets one time-coded request.
- Every cut checked for risk presentation before review.
- Built on Botminds: agents, data, screens, and governance on one platform.
Transcribed from the film’s narration. Captions are on the player.